Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2350]

Artificial intelligence and treatment decisions

Dr Pratik Shah - Massachusetts Institute of Technology, Cambridge, USA

Artificial intelligence and treatment decisions ( Dr Pratik Shah - Massachusetts Institute of Technology, Cambridge, USA )

Precision diagnosis for tailored therapy in acute lymphoblastic leukaemia

Dr Jean-Pierre Bourquin - University Children’s Hospital, Zurich, Switzerland

Precision diagnosis for tailored therapy in acute lymphoblastic leukaemia ( Dr Jean-Pierre Bourquin - University Children’s Hospital, Zurich, Switzerland )

Integrating, balancing and disregarding risk factors in paediatric acute...

Prof Anthony Moorman - Newcastle University, Newcastle, UK

Integrating, balancing and disregarding risk factors in paediatric acute lymphoblastic leukaemia ( Prof Anthony Moorman - Newcastle University, Newcastle, UK )

B-lymphoid transcriptional programme as a barrier against malignant...

Prof Markus Müschen - City of Hope Comprehensive Cancer Center, Los Angeles, USA

B-lymphoid transcriptional programme as a barrier against malignant transformation in acute lymphoblastic leukaemia ( Prof Markus Müschen - City of Hope Comprehensive Cancer Center, Los Angeles, USA )

Put a stop sign to aggressive multiple myeloma

Dr Francesca Gay - Azienda Ospedaliera Universitaria Città della Salute e della...

Put a stop sign to aggressive multiple myeloma ( Dr Francesca Gay - Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin, Italy )

Should you start treatment early in smouldering multiple myeloma?

Dr Albert Oriol - Josep Carreras Leukaemia Research Institute, Barcelona, Spain

Should you start treatment early in smouldering multiple myeloma? ( Dr Albert Oriol - Josep Carreras Leukaemia Research Institute, Barcelona, Spain )

Dr Alex Asiimwe, EFPIA lead for PIONEER, discusses the unique public-private...

Dr Alex Asiimwe - Director, BAYER AG, Medical affairs, Epidemiology

Dr Alex Asiimwe, EFPIA lead for PIONEER, discusses the unique public-private aspects of BD4BO ( Dr Alex Asiimwe - Director, BAYER AG, Medical affairs, Epidemiology )

Prof Anders Bjartell discusses the data sources and access of the PIONEER data...

Prof Anders Bjartell - Skåne University Hospital, Malmö, Lund University, Sweden

Prof Anders Bjartell discusses the data sources and access of the PIONEER data models ( Prof Anders Bjartell - Skåne University Hospital, Malmö, Lund University, Sweden )

Dr Billy Franks explains the importance of data analysis plans for PIONEER’s...

Dr Billy Franks - Astellas Pharma B.V.

Dr Billy Franks explains the importance of data analysis plans for PIONEER’s research questions ( Dr Billy Franks - Astellas Pharma B.V. )

Denis Horgan explains the importance of actively engaging policy makers in...

Denis Horgan - Executive Director, European Alliance for Personalised Medicine

Denis Horgan explains the importance of actively engaging policy makers in PIONEER ( Denis Horgan - Executive Director, European Alliance for Personalised Medicine )

Prof James N’Dow, Academic lead for PIONEER, reflects on the first twelve...

Prof James N’Dow - Chairperson, European Association of Urology Guidelines...

Prof James N’Dow, Academic lead for PIONEER, reflects on the first twelve months of the project ( Prof James N’Dow - Chairperson, European Association of Urology Guidelines Office )

Louise Fullwood explains the legal and ethical issues around data privacy...

Louise Fullwood - Legal Director, Pinsent Masons

Louise Fullwood explains the legal and ethical issues around data privacy within PIONEER ( Louise Fullwood - Legal Director, Pinsent Masons )

More from ecancer